Humanitarian Device Exemption
Dystonia IRB
1 other identifier
expanded_access
N/A
1 country
1
Brief Summary
The purpose of this study is to allow patients to undergo deep brain stimulation (DBS) surgery for the treatment of dystonia. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of the deep brain stimulator device in the treatment of this rare disorder. Use of DBS for dystonia is approved for humanitarian use by the FDA in the treatment of chronic, intractable (drug refractory) dystonia, including generalized and segmental dystonia, hemidystonia, and cervical dystonia (torticollis) in patients 7 years or older. Thus, this proposal request authorization by the IRB to allow patients at VUMC to access this HUD therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2007
CompletedFirst Posted
Study publicly available on registry
December 27, 2007
CompletedOctober 14, 2019
October 1, 2019
December 13, 2007
October 9, 2019
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Patients whose ages are in the range of 7 and 99 years old
- Patients who are diagnosed with chronic, intractable (drug refractory)primary dystonia, including generalized and or segmental dystonia, hemidystonia, and cervical dystonia (torticollis)as determined by a neurologist or neurosurgeon.
- Patients who have failed appropriate medical therapy as determined by the SMD conference
You may not qualify if:
- Patients younger than 7 years old
- Patients who are at significant surgical risk as determined by the neurosurgeon and/or anesthesiologist.
- Patients who have not had an adequate trial of medical or non-surgical therapy as determined by the SMD conference.
- Patients not deemed good candidates by the SMD conference group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter E Konrad, MD, Ph.D.
Vanderbilt University, Dept. Neurosurgery
- PRINCIPAL INVESTIGATOR
Dario Englot, MD PhD
Vanderbilt University, Dept. Neurosurgery
- PRINCIPAL INVESTIGATOR
Thomas L Davis, MD
Vanderbilt University, Dept. Neurology
- PRINCIPAL INVESTIGATOR
John Y Fang, MD
Vanderbilt University, Dept. Neurology
Study Design
- Study Type
- expanded access
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Director of Functional Neurosurgery
Study Record Dates
First Submitted
December 13, 2007
First Posted
December 27, 2007
Last Updated
October 14, 2019
Record last verified: 2019-10